(Q52648016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

1 reference

1 reference

ChEBI release 2020-05-28

ChEBI ID

16175

metabolomic profiling

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

R Madelaine Paredes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Marlon Quinones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Xiaoli Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Celina Valdez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Seema S Ahuja

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Dawn Velligan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Consuelo Walss-Bass

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

25 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

8 March 2020

https://academic.oup.com/ijnp/article-pdf/17/8/1139/17487098/17-8-1139.pdf

1 reference

26 April 2024

https://api.unpaywall.org/v2/10.1017/s1461145714000157?email=unpaywall_01@example.com

published in

The International Journal of Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1139-1148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

26 April 2024

https://api.unpaywall.org/v2/10.1017/s1461145714000157?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

cites work

Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Excessive insulin secretion in Japanese schizophrenic patients treated with antipsychotics despite normal fasting glucose levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Obesity and adipokines: effects on sympathetic overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Increased cortical kynurenate content in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

A reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Targeting glutamate synapses in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Lipid effects of psychiatric medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Neuroleptic Treatment Effect on Mitochondrial Electron Transport Chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

7 January 2021

Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

7 January 2021

Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

7 January 2021

Impact of substance use disorder on ADHD and its treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

7 January 2021

Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145714000157

7 January 2021

10.1017/S1461145714000157

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24565079%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference